Access the full text.
Sign up today, get DeepDyve free for 14 days.
Hogyu Han, P. Weinreb, P. Lansbury (1995)
The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?Chemistry & biology, 2 3
C. Lippa, Hideo Fujiwara, D. Mann, Benoit Giasson, M. Baba, M. Schmidt, L. Nee, Brendan O'Connell, D. Pollen, P. George-Hyslop, B. Ghetti, D. Nochlin, T. Bird, N. Cairns, V. Lee, T. Iwatsubo, J. Trojanowski (1998)
Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.The American journal of pathology, 153 5
J. George, Hui Jin, W. Woods, D. Clayton (1995)
Characterization of a novel protein regulated during the critical period for song learning in the zebra finchNeuron, 15
(1978)
Lewy bodies in cerebral cortex
K. Wakabayashi, M. Yoshimoto, S. Tsuji, H. Takahashi (1998)
α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophyNeuroscience Letters, 249
M. Polymeropoulos, J. Higgins, L. Golbe, W. Johnson, S. Ide, G. Iorio, G. Sanges, E. Stenroos, L. Pho, A. Schaffer, A. Lazzarini, R. Nussbaum, R. Duvoisin (1996)
Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23Science, 274
D. Dickson (2001)
Alpha-synuclein and the Lewy body disorders.Current opinion in neurology, 14 4
M. Spillantini, R., Anthony Crowther, R. Jakes, M. Hasegawa, M. Goedert (1998)
α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences of the United States of America, 95
J. Jenco, A. Rawlingson, B. Daniels, A. Morris (1998)
Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins.Biochemistry, 37 14
M. Okochi, J. Walter, A. Koyama, S. Nakajo, M. Baba, T. Iwatsubo, L. Meijer, P. Kahle, C. Haass (2000)
Constitutive Phosphorylation of the Parkinson's Disease Associated α-Synuclein*The Journal of Biological Chemistry, 275
P. James (1817)
An Essay on the Shaking PalsyThe Medico-Chirurgical Journal and Review, 4
M. Spillantini, Aspasia Divane, Michel Goedert (1995)
Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35.Genomics, 27 2
T. Ozawa, H. Takano, O. Onodera, Hisashi Kobayashi, T. Ikeuchi, R. Koide, K. Okuizumi, T. Shimohata, K. Wakabayashi, H. Takahashi, S. Tsuji (1999)
No mutation in the entire coding region of the α-synuclein gene in pathologically confirmed cases of multiple system atrophyNeuroscience Letters, 270
R. Crowther, R. Jakes, M. Spillantini, M. Goedert (1998)
Synthetic filaments assembled from C‐terminally truncated α‐synucleinFEBS Letters, 436
É. Mezey, A. Dehejia, G. Harta, M. Papp, M. Polymeropoulos, M. Brownstein (1998)
Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?Nature Medicine, 4
W. Colley, T. Sung, Richard Roll, J. Jenco, S. Hammond, Y. Altshuller, D. Bar-Sagi, A. Morris, M. Frohman (1997)
Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganizationCurrent Biology, 7
L. Forno (1996)
Neuropathology of Parkinson's DiseaseJournal of Neuropathology and Experimental Neurology, 55
K. Uéda, H. Fukushima, E. Masliah, Yu Xia, A. Iwai, M. Yoshimoto, D. Otero, J. Kondo, Y. Ihara, T. Saitoh (1993)
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 90 23
J. Flowers, P. Leigh, A. Davies, N. Ninkina, V. Buchman, J. Vaughan, N. Wood, J. Powell (1999)
Mutations in the gene encoding human persyn are not associated with amyotrophic lateral sclerosis or familial Parkinson's diseaseNeuroscience Letters, 274
H. Braak, D. Sandmann-Keil, W. Gai, E. Braak (1999)
Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by α-synuclein immunocytochemistryNeuroscience Letters, 265
É. Mezey, A. Dehejia, G. Harta, S. Suchy, R. Nussbaum, M. Brownstein, M. Polymeropoulos (1998)
Alpha synuclein is present in Lewy bodies in sporadic Parkinson's diseaseMolecular Psychiatry, 3
T. Arai, K. Uéda, K. Ikeda, H. Akiyama, C. Haga, H. Kondo, N. Kuroki, K. Niizato, S. Iritani, K. Tsuchiya (1999)
Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/α-synucleinNeuroscience Letters, 259
M. Baba, S. Nakajo, Ping-hui Tu, T. Tomita, K. Nakaya, V. Lee, J. Trojanowski, T. Iwatsubo (1998)
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.The American journal of pathology, 152 4
N. Ninkina, M. Alimova-Kost, J. Paterson, Liz Delaney, B. Cohen, S. Imreh, N. Gnuchev, A. Davies, V. Buchman (1998)
Organization, expression and polymorphism of the human persyn gene.Human molecular genetics, 7 9
K. Wakabayashi, S. Hayashi, A. Kakita, M. Yamada, Y. Toyoshima, M. Yoshimoto, H. Takahashi (1998)
Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophyActa Neuropathologica, 96
K. Wakabayashi, Kayo Matsumoto, K. Takayama, M. Yoshimoto, H. Takahashi (1997)
NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's diseaseNeuroscience Letters, 239
J.G. Culvenor (1999)
Non‐Aβ component of Alzheimer's disease amyloid (NAC) revisited, 155
W. Gai, J. Power, P. Blumbergs, J. Culvenor, P. Jensen (1999)
α‐Synuclein Immunoisolation of Glial Inclusions from Multiple System Atrophy Brain Tissue Reveals Multiprotein ComponentsJournal of Neurochemistry, 73
K. Conway, J. Harper, P. Lansbury (1998)
Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson diseaseNature Medicine, 4
M.G. Spillantini (1995)
Assignment of human α‐synuclein (SNCA) and α‐synuclein (SNCB) genes to chromosomes 4q21 and 5q35, 27
R. Krüger, W. Kuhn, T. Müller, D. Woitalla, M. Graeber, S. Kösel, H. Przuntek, J. Epplen, L. Schols, O. Riess (1998)
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 18
M.I. Papp (1989)
Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy, 94
S. Lincoln, K. Gwinn‐Hardy, J. Goudreau, M. Chartier-Harlin, M. Baker, V. Mouroux, F. Richard, A. Destée, E. Becquet, P. Amouyel, T. Lynch, J. Hardy, M. Farrer (1999)
No pathogenic mutations in the persyn gene in Parkinson's diseaseNeuroscience Letters, 259
S. Lincoln, R. Crook, M. Chartier-Harlin, K. Gwinn‐Hardy, M. Baker, V. Mouroux, F. Richard, E. Becquet, P. Amouyel, A. Destée, J. Hardy, M. Farrer (1999)
No pathogenic mutations in the β-synuclein gene in Parkinson's diseaseNeuroscience Letters, 269
D. Campion, Cosette Martin, Roland Heilig, F. Charbonnier, V. Moreau, J. Flaman, Jean Petit, D. Hannequin, Alexis Brice, Thierry Frebourg (1995)
The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease.Genomics, 26 2
R. Perry, D. Irving, G. Blessed, A. Fairbairn, E. Perry (1990)
Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderlyJournal of the Neurological Sciences, 95
C. Lavedan, C. Lavedan, E. Leroy, R. Torres, A. Dehejia, A. Dutra, S. Buchholtz, R. Nussbaum, M. Polymeropoulos (1998)
Genomic organization and expression of the human β-synuclein gene (SNCB)Genomics, 54
J. Woodard (1962)
CONCENTRIC HYALINE INCLUSION BODY FORMATION IN MENTAL DISEASE ANALYSIS OF TWENTY‐SEVEN CASESJournal of Neuropathology and Experimental Neurology, 21
J. Culvenor, C. Mclean, S. Cutt, B. Campbell, F. Maher, P. Jäkälä, T. Hartmann, K. Beyreuther, C. Masters, Qiao-Xin Li (1999)
Non-Aβ Component of Alzheimer's Disease Amyloid (NAC) Revisited: NAC and α-Synuclein Are Not Associated with Aβ AmyloidAmerican Journal of Pathology, 155
W. Gai, J. Power, P. Blumbergs, W. Blessing (1998)
Multiple-system atrophy: a new α-synuclein disease?The Lancet, 352
M. Goedert (1998)
Alpha‐synuclein and the Lewy body, 1
T. Tobe, S. Nakajo, Atsutaka Tanaka, Akira Mitoya, K. Omata, K. Nakaya, Motowo Tomita, Yasuharu Nakamura (1992)
Cloning and Characterization of the cDNA Encoding a Novel Brain‐Specific 14‐kDa ProteinJournal of Neurochemistry, 59
L. Serpell, J. Berriman, R. Jakes, M. Goedert, R. Crowther (2000)
Fiber diffraction of synthetic a-synuclein filaments shows amyloid-like cross-b conformation
K. Arima, K. Uéda, N. Sunohara, S. Hirai, Y. Izumiyama, H. Tonozuka-Uehara, M. Kawai (1998)
Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodiesBrain Research, 808
B. Giasson, K. Uryu, J. Trojanowski, V. Lee (1999)
Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro *The Journal of Biological Chemistry, 274
P. Weinreb, Weiguo Zhen, Anna Poon, K. Conway, P. Lansbury (1996)
NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.Biochemistry, 35 43
S. Wood, J. Wypych, S. Steavenson, J. Louis, M. Citron, A. Biere (1999)
α-Synuclein Fibrillogenesis Is Nucleation-dependentThe Journal of Biological Chemistry, 274
M. Spillantini, M. Schmidt, V. Lee, J. Trojanowski, R. Jakes, M. Goedert (1997)
α-Synuclein in Lewy bodiesNature, 388
Xiaohua Chen, H. Silva, M. Pettenati, P. Rao, P. George-Hyslop, A. Roses, Yu Xia, K. Horsburgh, K. Uéda, T. Saitoh (1995)
The human NACP/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis.Genomics, 26 2
D. Dickson, Wei-Kuang Liu, J. Hardy, M. Farrer, N. Mehta, R. Uitti, M. Mark, Thomas Zimmerman, L. Golbe, J. Sage, A. Sima, C. D'amato, R. Albin, S. Gilman, S. Yen (1999)
Widespread Alterations of α-Synuclein in Multiple System AtrophyAmerican Journal of Pathology, 155
R.H. Perry (1990)
Senile dementia of the Lewy body type, 85
Stephen Wood, J. Wypych, S. Steavenson, J. Louis, M. Citron, A. Biere (1999)
alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease.The Journal of biological chemistry, 274 28
M. Irizarry, W. Growdon, T. Gómez-Isla, K. Newell, J. George, D. Clayton, B. Hyman (1998)
Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein ImmunoreactivityJournal of Neuropathology and Experimental Neurology, 57
H. Okazaki, L. Lipkin, S. Aronson (1961)
DIFFUSE INTRACYTOPLASMIC GANGLIONIC INCLUSIONS (LEWY TYPE) ASSOCIATED WITH PROGRESSIVE DEMENTIA AND QUADRIPARESIS IN FLEXIONJournal of Neuropathology and Experimental Neurology, 20
Y. Shibasaki, D. Baillie, D. Clair, A. Brookes (1995)
High-resolution mapping of SNCA encoding α-synuclein, the non-Aβ component of Alzheimer’s disease amyloid precursor, to human chromosome 4q21.3→q22 by fluorescence in situ hybridizationCytogenetic and Genome Research, 71
P. Tu, J. Galvin, M. Baba, Benoit Giasson, T. Tomita, S. Leight, S. Nakajo, T. Iwatsubo, J. Trojanowski, V. Lee (1998)
Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synucleinAnnals of Neurology, 44
S. Kato (1990)
Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies, 79
C. Lippa, M. Schmidt, V. Lee, J. Trojanowski (1999)
Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's diseaseAnnals of Neurology, 45
V. Buchman, H. Hunter, L. Pinõn, J. Thompson, Eugenia Privalova, N. Ninkina, A. Davies (1998)
Persyn, a Member of the Synuclein Family, Has a Distinct Pattern of Expression in the Developing Nervous SystemThe Journal of Neuroscience, 18
C. Lavedan, E. Leroy, A. Dehejia, S. Buchholtz, A. Dutra, R. Nussbaum, M. Polymeropoulos (1998)
Identification, localization and characterization of the human γ-synuclein geneHuman Genetics, 103
L. Golbe, G. Iorio, V. Bonavita, Douglas Miller, R. Duvoisin (1990)
A large kindred with autosomal dominant Parkinson's diseaseAnnals of Neurology, 27
A. Athanassiadou, G. Voutsinas, L. Psiouri, E. Leroy, M. Polymeropoulos, A. Ilias, G. Maniatis, T. Papapetropoulos (1999)
Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein.American journal of human genetics, 65 2
R. Jakes, M. Spillantini, M. Goedert (1994)
Identification of two distinct synucleins from human brainFEBS Letters, 345
R. Jakes, R. Crowther, V. Lee, J. Trojanowski, T. Iwatsubo, M. Goedert (1999)
Epitope mapping of LB509, a monoclonal antibody directed against human α-synucleinNeuroscience Letters, 269
L. Maroteaux, R. Scheller (1991)
The rat brain synucleins; family of proteins transiently associated with neuronal membrane.Brain research. Molecular brain research, 11 3-4
O. El-Agnaf, R. Jakes, M. Curran, A. Wallace (1998)
Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α‐synuclein protein implicated in Parkinson's diseaseFEBS Letters, 440
M. Spillantini, R. Crowther, R. Jakes, N. Cairns, P. Lantos, M. Goedert (1998)
Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodiesNeuroscience Letters, 251
L. Maroteaux, JT Campanelli, R. Scheller (1988)
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal, 8
A. Takeda, M. Mallory, M. Sundsmo, W. Honer, L. Hansen, E. Masliah (1998)
Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.The American journal of pathology, 152 2
R. Krüger, W. Kuhn, T. Müller, D. Woitalla, M. Graeber, S. Kösel, H. Przuntek, J. Epplen, L. Schöls, O. Riess (1998)
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.Nature genetics, 18 2
M. Bennett, J. Bishop, Y. Leng, P. Chock, T. Chase, M. Mouradian (1999)
Degradation of α-Synuclein by Proteasome*The Journal of Biological Chemistry, 274
S. Arawaka, Y. Saito, S. Murayama, H. Mori (1998)
Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synucleinNeurology, 51
H. Ji, Y. Liu, T. Jia, M. Wang, J. Liu, G. Xiao, B. Joseph, C. Rosen, Y. Shi (1997)
Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.Cancer research, 57 4
K. Wakabayashi, M. Yoshimoto, T. Fukushima, R. Koide, Y. Horikawa, T. Morita, Hoyu Takahashi (1999)
Widespread occurrence of α‐synuclein/NACP‐immunoreactive neuronal inclusions in juvenileand adult‐onset Hallervorden–Spatz diseasewith Lewy bodiesNeuropathology and Applied Neurobiology, 25
P. Duffy, V. Tennyson (1965)
Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra and Locus Caeruleus in Parkinson's DiseaseJournal of Neuropathology and Experimental Neurology, 24
F. Lewy
Paralysis agitans. I. Pathologische Anatomie, 3
M. Spillantini, M. Tolnay, S. Love, M. Goedert (1999)
Microtubule-associated protein tau, heparan sulphate and α-synuclein in several neurodegenerative diseases with dementiaActa Neuropathologica, 97
Benoit Giasson, R. Jakes, M. Goedert, J. Duda, S. Leight, J. Trojanowski, V. Lee (2000)
A panel of epitope‐specific antibodies detects protein domains distributed throughout human α‐synuclein in lewy bodies of Parkinson's diseaseJournal of Neuroscience Research, 59
P. Jensen, Morten Nielsen, R. Jakes, C. Dotti, M. Goedert (1998)
Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson’s Disease Mutation*The Journal of Biological Chemistry, 273
K. Uéda, T. Saitoh, H. Mori (1994)
Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid.Biochemical and biophysical research communications, 205 2
J. Graham, D. Oppenheimer (1969)
Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy.Journal of Neurology, Neurosurgery & Psychiatry, 32
L. Narhi, S. Wood, S. Steavenson, Yijia Jiang, Gay‐May Wu, D. Anafi, Stephen Kaufman, F. Martin, K. Sitney, P. Denis, J. Louis, J. Wypych, A. Biere, M. Citron (1999)
Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation*The Journal of Biological Chemistry, 274
M. Papp, J. Kahn, P. Lantos (1989)
Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)Journal of the Neurological Sciences, 94
K. Arima, K. Uéda, N. Sunohara, K. Arakawa, S. Hirai, Minako Nakamura, H. Tonozuka-Uehara, M. Kawai (1998)
NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophyActa Neuropathologica, 96
Davis Ws, A. Jonas, D. Clayton, J. George (1998)
Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes*The Journal of Biological Chemistry, 273
M. Polymeropoulos, C. Lavedan, E. Leroy, S. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W. Johnson, A. Lazzarini, R. Duvoisin, G. Iorio, L. Golbe, R. Nussbaum (1997)
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 276
L.A. Hansen (1990)
The Lewy body variant of Alzheimer's disease: a clinical and pathological entity, 40
T. Bayer, P. Jäkälä, T. Hartmann, L. Havas, C. Mclean, J. Culvenor, Qiao-Xin Li, C. Masters, P. Falkai, K. Beyreuther (1999)
α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque coresNeuroscience Letters, 266
A. Surguchov, I. Surgucheva, E. Solessio, W. Baehr (1999)
Synoretin—A New Protein Belonging to the Synuclein FamilyMolecular and Cellular Neuroscience, 13
L. Hansen, D. Salmon, D. Galasko, E. Masliah, R. Katzman, R. DeTeresa, L. Thal, M. Pay, Richard Hofstetter, M. Klauber, V. Rice, N. Butters, M. Alford (1990)
The Lewy body variant of Alzheimer's diseaseNeurology, 40
Abstract: Parkinson's disease is the second most common neurodegenerative disease, after Alzheimer's disease. Neuropathologically, it is characterized by the degeneration of populations of nerve cells that develop filamentous inclusions in the form of Lewy bodies and Lewy neurites. Recent work has shown that the filamentous inclusions of Parkinson's disease are made of the protein α‐synuclein and that rare, familial forms of Parkinson's disease are caused by missense mutations in the α‐synuclein gene. Besides Parkinson's disease, the filamentous inclusions of two additional neurodegenerative diseases, namely, dementia with Lewy bodies and multiple system atrophy, have also been found to be made of α‐synuclein. Recombinant α‐synuclein has been shown to assemble into filaments with similar morphologies to those found in the human diseases and with a cross‐β fiber diffraction pattern. The new work has established the α‐synucleinopathies as a major class of neurodegenerative disease.
Annals of the New York Academy of Sciences – Wiley
Published: Jan 1, 2000
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.